Long‐term dosimetric stability of multiple TomoTherapy delivery systems

&NA; The dosimetric stability of six TomoTherapy units was analyzed to investigate changes in performance over time and with system upgrades. Energy and output were tracked using monitor chamber signal, onboard megavoltage computed tomography (MVCT) detector profile, and external ion chamber measurements. The systems (and monitoring periods) include three Hi‐Art (67, 61, and 65 mos.), two TomoHDA (31 and 26 mos.), and one Radixact unit (11 mos.), representing approximately 10 years of clinical use. The four newest systems use the Dose Control Stability (DCS) system and Fixed Target Linear Accelerator (linac) (FTL). The output stability is reported as deviation from reference monitor chamber signal for all systems and/or from an external chamber signal. The energy stability was monitored using relative (center versus off‐axis) MVCT detector signal (beam profile) and/or the ratio of chamber measurements at 2 depths. The clinical TomoHDA data were used to benchmark the Radixact stability, which has the same FTL but runs at a higher dose rate. The output based on monitor chamber data of all systems is very stable. The standard deviation of daily output on the non‐DCS systems was 0.94–1.52%. As expected, the DCS systems had improved standard deviation: 0.004–0.06%. The beam energy was also very stable for all units. The standard deviation in profile flatness was 0.23–0.62% for rotating target systems and 0.04–0.09% for FTL. Ion chamber output and PDD ratios supported these results. The output stability on the Radixact system during extended treatment delivery (20, 30, and 40 min) was comparable to a clinical TomoHDA system. For each system, results are consistent between different measurement tools and techniques, proving not only the dosimetric stability, but also these quality parameters can be confirmed with various metrics. The replacement history over extended time periods of the major dosimetric components of the different delivery systems (target, linac, and magnetron) is also reported.

[1]  W. Grant,et al.  QA for helical tomotherapy: report of the AAPM Task Group 148. , 2010, Medical physics.

[2]  Fang-Fang Yin,et al.  Task Group 142 report: quality assurance of medical accelerators. , 2009, Medical physics.

[3]  M. Geurts,et al.  Longitudinal study using a diode phantom for helical tomotherapy IMRT QA. , 2009, Medical physics.

[4]  D. Verellen,et al.  A diagnostic tool for basic daily quality assurance of a tomotherapy Hi•Art machine , 2009, Journal of applied clinical medical physics.

[5]  Riccardo Calandrino,et al.  Results of a two-year quality control program for a helical tomotherapy unit. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  C. Usher,et al.  A dosimetric comparison between two intensity-modulated radiotherapy techniques: tomotherapy vs dynamic linear accelerator. , 2008, The British journal of radiology.

[7]  H. Tien,et al.  Helical Irradiation of the Total Skin with Dose Painting to Replace Total Skin Electron Beam Therapy for Therapy-Refractory Cutaneous CD4+ T-Cell Lymphoma , 2013, BioMed research international.

[8]  Patrick A Kupelian,et al.  Dosimetric effects of rotational output variation and x-ray target degradation on helical tomotherapy plans. , 2009, Medical physics.

[9]  F. Bochud,et al.  Stability of the Helical TomoTherapy Hi·Art II detector for treatment beam irradiations , 2014, Journal of applied clinical medical physics.

[10]  J O Deasy,et al.  Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. , 1993, Medical physics.

[11]  Mika Kapanen,et al.  Analysis of quality control data of eight modern radiotherapy linear accelerators: the short- and long-term behaviours of the outputs and the reproducibility of quality control measurements , 2006, Physics in medicine and biology.

[12]  Gustavo H. Olivera,et al.  TOMOTHERAPY QUALITY ASSURANCE (TQA): A FAST AND COMPREHENSIVE SOFTWARE TOOL , 2009 .

[13]  Timothy E Schultheiss,et al.  Image-guided total marrow and total lymphatic irradiation using helical tomotherapy. , 2007, International journal of radiation oncology, biology, physics.

[14]  B. Jeremic,et al.  Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. , 2007, International journal of radiation oncology, biology, physics.

[15]  Jan J. Wilkens,et al.  Measurements to predict the time of target replacement of a helical tomotherapy , 2011, Journal of applied clinical medical physics.

[16]  Craig M. Lancaster,et al.  First experiences in using a dose control system on a TomoTherapy Hi·Art II , 2015, Journal of applied clinical medical physics.

[17]  T R Mackie,et al.  History of tomotherapy , 2006, Physics in medicine and biology.